Search Results - "Runbeck, Erin"

Utilizing Immunocytokines for Cancer Therapy by Runbeck, Erin, Crescioli, Silvia, Karagiannis, Sophia N, Papa, Sophie

“…Cytokine therapy for cancer has indicated efficacy in certain diseases but is generally accompanied by severe toxicity. The field of antibody-cytokine fusion…”
Get full text

Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs by Yarmarkovich, Mark, Marshall, Quinlen F, Warrington, John M, Premaratne, Rasika, Farrel, Alvin, Groff, David, Li, Wei, di Marco, Moreno, Runbeck, Erin, Truong, Hau, Toor, Jugmohit S, Tripathi, Sarvind, Nguyen, Son, Shen, Helena, Noel, Tiffany, Church, Nicole L, Weiner, Amber, Kendsersky, Nathan, Martinez, Dan, Weisberg, Rebecca, Christie, Molly, Eisenlohr, Laurence, Bosse, Kristopher R, Dimitrov, Dimiter S, Stevanovic, Stefan, Sgourakis, Nikolaos G, Kiefel, Ben R, Maris, John M

“…The majority of oncogenic drivers are intracellular proteins, thus constraining their immunotherapeutic targeting to mutated peptides (neoantigens) presented…”
Get full text

Optimising Car T Cell Immunotherapy with a Tumour Microenvironment Targeted Immunocytokine by Runbeck, Erin

“…Prostate cancer (PCa) is the most common malignancy in men in the UK. However, the 5-year survival rate of stage IV PCa is 30% and the median survival for the…”
Get full text

Targeting of intracellular oncoproteins with peptide-centric CARs by Yarmarkovich, Mark, Marshall, Quinlen F., Warrington, John M., Premaratne, Rasika, Farrel, Alvin, Groff, David, Li, Wei, di Marco, Moreno, Runbeck, Erin, Truong, Hau, Toor, Jugmohit S., Tripathi, Sarvind, Nguyen, Son, Shen, Helena, Noel, Tiffany, Church, Nicole L., Weiner, Amber, Kendsersky, Nathan, Martinez, Dan, Weisberg, Rebecca, Christie, Molly, Eisenlohr, Laurence, Bosse, Kristopher R., Dimitrov, Dimiter S., Stevanovic, Stefan, Sgourakis, Nikolaos G., Kiefel, Ben R., Maris, John M.

“…The majority of oncogenic drivers are intracellular proteins, constraining their immunotherapeutic targeting to mutated peptides (neoantigens) presented by…”
Get full text

Retraction Note: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs by Yarmarkovich, Mark, Marshall, Quinlen F., Warrington, John M., Premaratne, Rasika, Farrel, Alvin, Groff, David, Li, Wei, di Marco, Moreno, Runbeck, Erin, Truong, Hau, Toor, Jugmohit S., Tripathi, Sarvind, Nguyen, Son, Shen, Helena, Noel, Tiffany, Church, Nicole L., Weiner, Amber, Kendsersky, Nathan, Martinez, Dan, Weisberg, Rebecca, Christie, Molly, Eisenlohr, Laurence, Bosse, Kristopher R., Dimitrov, Dimiter S., Stevanovic, Stefan, Sgourakis, Nikolaos G., Kiefel, Ben R., Maris, John M.

“…Following the publication of our manuscript, a new high-resolution structure of the HLA-A·24:02/PHOX2B peptide/10LH scFv complex by X-ray crystallography…”
Get full text

RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs by Yarmarkovich, Mark, Marshall, Quinlen F., Warrington, John M., Premaratne, Rasika, Farrel, Alvin, Groff, David, Li, Wei, di Marco, Moreno, Runbeck, Erin, Truong, Hau, Toor, Jugmohit S., Tripathi, Sarvind, Nguyen, Son, Shen, Helena, Noel, Tiffany, Church, Nicole L., Weiner, Amber, Kendsersky, Nathan, Martinez, Dan, Weisberg, Rebecca, Christie, Molly, Eisenlohr, Laurence, Bosse, Kristopher R., Dimitrov, Dimiter S., Stevanovic, Stefan, Sgourakis, Nikolaos G., Kiefel, Ben R., Maris, John M.

“…The majority of oncogenic drivers are intracellular proteins, thus constraining their immunotherapeutic targeting to mutated peptides (neoantigens) presented…”
Get full text

Abstract 699: NF-kB is a master regulator of resistance to therapy in high-risk neuroblastoma by Grossmann, Liron D., Uzun, Yasin, Lindsay, Jarrett, Chen, Chia-Hui, Wingrove, Catherine, Gao, Peng, Thadi, Anusha, Marshall, Quinlen, Kendsersky, Nathan M., Surrey, Lea, Martinez, Daniel, Mycek, Emily, Casey, Colleen, Krytska, Kateryna, Tsang, Matthew, Wolpaw, Adam, Groff, David N., Runbeck, Erin, McDevitt, Jayne, Diep, Dinh, Patel, Tasleema, Bernt, Kathrin M., Dang, Chi, Zhang, Kun, Mosse, Yael P., Tan, Kai, Maris, John M.

“…BACKGROUND High-risk neuroblastoma is a pediatric cancer arising from the developing sympathetic nervous system with a 50% relapse rate that is typically…”
Get full text